Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Feb 2018

Caswell-Jin Jennifer L, Gupta Tanya, Hall Evan, Petrovchich Iva M, Mills Meredith A, Kingham Kerry E, Koff Rachel, Chun Nicolette M, Levonian Peter, Lebensohn Alexandra P, Ford James M, Kurian Allison W

Abstract excerpt

PurposeWe examined racial/ethnic differences in the usage and results of germ-line multiple-gene sequencing (MGS) panels to evaluate hereditary cancer risk.MethodsWe collected genetic testing results and clinical information from 1,483 patients who underwent MGS at Stanford University between 1 January 2013 and 31 December 2015.ResultsAsians and Hispanics presented for MGS at younger ages than whites (48 and 47...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Neoplastic Syndromes, Hereditary

Share to Racial Groups

Share to Risk Assessment

Share to Young Adult

Source

Identifiers

PMID: 28749474
DOI: 10.1038/gim.2017.96

Genes

BRCA1
CHEK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.PMID 28749474Read ↗

Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multi-gene panel testingSemantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multigene panel testing.Semantic proximity Read ↗

Multigene panel testing reveals the spectrum of non-BRCA germline variants in BRCA1/2-negative breast, ovarian, and prostate cancer patients from a Turkish cohort.Semantic proximity Read ↗

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.Semantic proximity Read ↗

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional StudySemantic proximity Read ↗

The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.Semantic proximity Read ↗

Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel.Semantic proximity Read ↗

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsSemantic proximity Read ↗

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer PatientsSemantic proximity Read ↗

Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022.Semantic proximity Read ↗

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.